To Modify or Not to Modify: Allele‐Specific Effects of 3'UTR‐ KCNQ1 Single Nucleotide Polymorphisms on Clinical Phenotype in a Long QT 1 Founder Population Segregating a Dominant‐Negative Mutation
Open Access
- 14 September 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 11 (18) , e025981
Abstract
Background: There are conflicting reports with regard to the allele‐specific gene suppression effects of single nucleotide polymorphisms (SNPs) in the 3'untranslated region (3'UTR) of the KCNQ1 gene in long QT syndrome type 1 (LQT1) populations. Here we assess the allele‐specific effects of 3 previously published 3'UTR‐ KCNQ1 's SNPs in a LQT1 founder population segregating a dominant‐negative mutation. Methods and Results: Bidirectional sequencing of the KCNQ1 ' s 3'UTR was performed in the p.Y111C founder population (n=232, 147 genotype positive), with a minor allele frequency of 0.1 for SNP1 (rs2519184) and 0.6 for linked SNP2 (rs8234) and SNP3 (rs107980). Allelic phase was assessed in trios aided by haplotype data, revealing a high prevalence of derived SNP2/3 in cis with p.Y111C (89%). Allele‐specific association analyses, corrected using a relatedness matrix, were performed between 3'UTR‐ KCNQ1 SNP genotypes and clinical phenotypes. SNP1 in trans was associated with a significantly higher proportion of symptomatic phenotype compared with no derived SNP1 allele in trans (58% versus 32%, corrected P =0.027). SNP2/3 in cis was associated with a significantly lower proportion of symptomatic phenotype compared with no derived SNP2/3 allele in cis (32% versus 69%, corrected P =0.010). Conclusions: Allele‐specific modifying effects on symptomatic phenotype of 3'UTR‐ KCNQ1 SNPs rs2519184, rs8234, and rs107980 were seen in a LQT1 founder population segregating a dominant‐negative mutation. The high prevalence of suppressive 3'UTR‐ KCNQ1 SNPs segregating with the founder mutation could contribute to the previously documented low incidence of cardiac events in heterozygous carriers of the p.Y111C KCNQ1 mutation.Keywords
This publication has 18 references indexed in Scilit:
- Variants in the 3′ untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific mannerEuropean Heart Journal, 2011
- Origin of the Swedish long QT syndrome Y111C/KCNQ1 founder mutationHeart Rhythm, 2011
- Sudden cardiac death, founder populations, and mushrooms: What is the link with gold mines and modifier genes?Heart Rhythm, 2011
- Low Incidence of Sudden Cardiac Death in a Swedish Y111C Type 1 Long-QT syndrome PopulationCirculation: Cardiovascular Genetics, 2009
- Case‐control association testing in the presence of unknown relationshipsGenetic Epidemiology, 2009
- The Common Long-QT Syndrome Mutation KCNQ1/A341V Causes Unusually Severe Clinical Manifestations in Patients With Different Ethnic BackgroundsCirculation, 2007
- The N-Terminal Juxtamembranous Domain of KCNQ1 Is Critical for Channel Surface ExpressionCirculation Research, 2006
- The KCNQ1 Potassium Channel: From Gene to Physiological FunctionPhysiology, 2005
- Novel Case-Control Test in a Founder Population Identifies P-Selectin as an Atopy-Susceptibility LocusThe American Journal of Human Genetics, 2003
- Phenotypes of Patients with “Simple” Mendelian Disorders Are Complex Traits: Thresholds, Modifiers, and Systems DynamicsThe American Journal of Human Genetics, 2000